EUVIMEDEUVIMED entdecken
Crossref

Development of a New 1,2,4-butanetriol Biosynthesis Pathway in an Engineered Homoserine-producing Strain of Escherichia coli

Yujun Zhang, Lin Chen, Antu Thomas, An-Ping Zeng

Synthetic Biology and Engineering · 2023

DOI: 10.35534/sbe.2023.10007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Synthetic Biology and Engineering, 2023. Verfasst von Yujun Zhang und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Zhang, Y., Chen, L., Thomas, A., & Zeng, A. (2023). Development of a New 1,2,4-butanetriol Biosynthesis Pathway in an Engineered Homoserine-producing Strain of Escherichia coli. Synthetic Biology and Engineering. https://doi.org/10.35534/sbe.2023.10007

Vancouver

Zhang Y, Chen L, Thomas A, Zeng A. Development of a New 1,2,4-butanetriol Biosynthesis Pathway in an Engineered Homoserine-producing Strain of Escherichia coli. Synthetic Biology and Engineering. 2023. doi:10.35534/sbe.2023.10007

BibTeX
@article{Zhang2023,
  author = {Zhang, Yujun and Chen, Lin and Thomas, Antu and Zeng, An-Ping},
  title = {Development of a New 1,2,4-butanetriol Biosynthesis Pathway in an Engineered Homoserine-producing Strain of Escherichia coli},
  journal = {Synthetic Biology and Engineering},
  year = {2023},
  doi = {10.35534/sbe.2023.10007}
}
Kostenlos starten →